Franklin Resources
FBRX icon

Franklin Resources’s Forte Biosciences FBRX Stock Holding History

Franklin Resources’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-30,467
Closed -$25.6M – 2468
2021
Q2 		$25.6M Sell
30,467
-2,540
-8% -$2.29M 0.01% 806
2021
Q1 		$28.3M Sell
33,007
-9,148
-22% -$7.49M 0.01% 762
2020
Q4 		$38.4M Buy
42,155
+3,401
+9% +$3.2M 0.02% 663
2020
Q3 		$47M Buy
+38,754
New +$25.7M 0.02% 569

Other funds holding FBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
OQS
Occudo Quantitative Strategies Fort Lauderdale, Florida $1.88B AUM 35.68% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Franklin Resources's FBRX Position: Q3 2021 in Review

Franklin Resources sold out of Forte Biosciences (FBRX) in Q3 2021, closing a stake of 30,467 shares — an estimated $25.6M sold.

Franklin Resources first reported a position in FBRX in Q3 2020 and held it in 4 quarters. The position peaked at $47M in Q3 2020. 57 funds tracked by Wall St. Rank hold FBRX as of Q3 2021.

  • Franklin Resources reported no remaining Forte Biosciences position as of Q3 2021 after selling out during the quarter.
  • Franklin Resources sold 30,467 Forte Biosciences shares in Q3 2021, an estimated $25.6M.
  • Franklin Resources first reported a position in Forte Biosciences in Q3 2020 and held it in 4 quarters.
  • Franklin Resources's Forte Biosciences position peaked at $47M in Q3 2020.
  • 57 funds tracked by Wall St. Rank held Forte Biosciences as of Q3 2021.

Based on Franklin Resources's 13F filing for Q3 2021, filed 12 Nov 2021.